2013年之前,全球約有320萬人患有鐮型紅血球疾病;另外約有4300萬人具有鐮型紅血球疾病表徵[7]。據信大約80%的鐮型紅血球疾病病例出現在撒哈拉沙漠以南的非洲[8]。此外,印度部分區域、阿拉伯半島以及世界各地的非裔地區也是經常有病例出現的地方[9]。在1990年,此疾病造成11萬3千人死亡,到了2013,此疾病已經造成17萬6千的人口死亡[10] 。此疾病最初是記載在1910年美國醫師詹姆斯·赫里克所寫的醫學文獻[11][12] 。1949年,此病的遺傳現象被E. A. Beet和J. V. Neel所確認 。在1954年,鐮型紅血球疾病表徵有能力對瘧疾產生抵抗性的效果已有相關記載論述[12]。
^Global Burden of Disease Study 2013, Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.. Lancet (London, England). 22 August 2015, 386 (9995): 743–800. PMID 26063472. doi:10.1016/s0140-6736(15)60692-4.
^Savitt TL, Goldberg MF. Herrick's 1910 case report of sickle cell anemia. The rest of the story. JAMA. Jan 1989, 261 (2): 266–71. PMID 2642320. doi:10.1001/jama.261.2.266.
^National Libray of Medicine. URL = ghr.nlm.nih.gov/condition/sickle-cell-disease
^Reference, Genetics Home. sickle cell disease. Genetics Home Reference. [2016-05-07]. (原始内容存档于2016-05-15).
^Green NS, Fabry ME, Kaptue-Noche L, Nagel RL. Senegal haplotype is associated with higher HbF than Benin and Cameroon haplotypes in African children with sickle cell anemia. Am. J. Hematol. Oct 1993, 44 (2): 145–6. ISSN 0361-8609. PMID 7505527. doi:10.1002/ajh.2830440214.
參考文獻
Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, Terrin M. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.N Engl J Med 1995;332:1317-22. PMID 12672732.
Chestnut, D. (1994). Perceptions of ethnic and cultural factors in the delivery of services in the treatment of sickle cell disease. Journal of Health and Social Policy, 5(3/4), 236.